Products at risk.
Curfman
Gregory D
GD
Morrissey
Stephen
S
Drazen
Jeffrey M
JM
D000280:Administration, Inhalation; D000420:Albuterol / Q000031:analogs & derivatives / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001507:Beclomethasone / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D057186:Comparative Effectiveness Research; D018592:Cross-Over Studies; D004345:Drug Industry; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D010919:Placebos; D000068299:Salmeterol Xinafoate; D012602:Scopolamine Derivatives / Q000627:therapeutic use*; D000069447:Tiotropium Bromide
D001993:Bronchodilator Agents; D018680:Cholinergic Antagonists; D005938:Glucocorticoids; D010919:Placebos; D012602:Scopolamine Derivatives; D000068299:Salmeterol Xinafoate; D001507:Beclomethasone; D000420:Albuterol; D000069447:Tiotropium Bromide